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Background/aim: The present observational study aimed to determine the predictive value of 3-year recurrence adenoma characteristics
at baseline conventional colonoscopy in patients with high-risk adenoma.
Materials and methods: A total of 47 patients with high-risk adenoma at baseline colonoscopy were followed up and underwent a
surveillance colonoscopy at 3 years. Correlations between adenoma recurrence and baseline adenoma characteristics (size, number,
histological features, and location) were analyzed.
Results: Among 135 patients with high-risk adenoma, 47 patients (35%) who underwent surveillance colonoscopy at 3 years following
baseline colonoscopy were included in the study. In these 47 patients, at least one new adenoma was detected in 19 (40.4%) patients, and
new advanced adenomas were detected in 5 (10.6%) patients during the surveillance colonoscopy. No significant difference was found
in patients who had adenoma recurrence versus those who did not in terms of size of adenomas (P = 0.143), number of adenomas (P =
0.562), histological properties of adenomas (P = 0.658), or locations of adenomas (P = 0.567).
Conclusion: Baseline adenoma characteristics were not associated with the recurrence of adenomas or advanced adenomas in patients
with high-risk adenoma.
Key words: Colonoscopy, adenoma characteristics, high-risk adenoma, surveillance

1. Introduction
Colorectal cancer (CRC), which is still associated with
very high incidence and mortality rates, is the second
most commonly diagnosed cancer in males and the third
in females around the world (1–3). However, survival from
CRC has seen an improvement over the past 30 years (4).
Screening for CRC is recommended after 50 years of age
for individuals at average risk (5–7). It is recognized that
more than 95% of all CRCs develop from adenomas and it is
accepted that the majority of CRC arise from the adenoma–
carcinoma sequence (8–11). The risk of an adenoma
becoming malignant is greatest for advanced adenoma
(AA) (adenoma with size ≥1 cm, villous elements, or highgrade dysplasia) (8,12). In the CRC screening guidelines
patients with adenomas were stratified at their baseline
colonoscopy into those at lower risk or increased risk for a
subsequent advanced neoplasia (2,6,8). The low-risk group
refers to patients with 1–2 tubular adenomas <10 mm in
diameter, while the high-risk group refers to patients with
* Correspondence: tfksolak@yahoo.com.tr
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tubular adenoma ≥10 mm, 3 or more adenomas, adenoma
with villous elements, or high-grade dysplasia (6). The
guideline for colonoscopy surveillance after screening and
polypectomy recommends a 3-year surveillance interval for
patients in the high-risk group and a 5-year surveillance
interval for those in the low-risk group (6).
According to a recent meta-analysis, it was
hypothesized that the size of an adenoma is a more
important determinant of adenoma recurrence (AR) than
the villous component or high-grade dysplastic content
(12). Although Martinez et al. (13) suggested that the size
and number of removal adenomas were two important
predictors of AR at follow-up colonoscopy, it is still not
known exactly which adenoma feature is more important
than the others for AR.
The aim of the present study was to determine the
baseline patient and colorectal adenoma characteristics
that are risk factors for AR at 3-year surveillance
colonoscopy in patients with high-risk adenoma.
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2. Materials and methods
2.1. Patient selection
This was a prospective study of patients undergoing
surveillance colonoscopy after removal of colorectal
adenomatous polyps. Data of 3954 patients who
underwent total colonoscopy for various indications
between January 2007 and December 2009 were reviewed.
Patients with a personal history of CRC, colorectal polyps,
inflammatory bowel diseases, family history of CRC,
hereditary nonpolyposis CRC, familial adenomatous
polyposis, malignant polyps, or incomplete colonoscopies
were excluded. The initial enrollment criteria included
patients with a first-time diagnosis of at least one
histologically confirmed adenoma, which was removed
during the diagnostic complete colonoscopy, and over 20
years of age. From the database we identified 398 patients
who had 1 or more adenomas removed at complete

colonoscopy. Of the 398 patients, 135 who were in the
high-risk group (high-risk patients) were included in the
study. High-risk patients were defined as having tubular
adenomas ≥10 mm, 3 or more adenomas, adenomas with
at least 20% villous elements, or high-grade dysplasia.
Then we contacted those patients by telephone to invite
them for CRC screening with colonoscopy; surveillance
colonoscopies after the removal of colorectal adenomas
were performed from 2010 to 2012. Some patients
declined to have follow-up colonoscopy at 3 years, some
patients’ contact details could not be obtained, and some
patients died. Clinical follow-up colonoscopy at 3 years
was performed for 47 of the 135 patients. At both baseline
and 3-year examinations, the characteristics of adenomas
and patients were noted. We considered a recurrence as
1 or more adenomas detected in follow-up colonoscopy.
The patient selection schema is provided in Figure 1. The

Figure 1. Patient selection §HNPCC: Hereditary nonpolyposis colorectal cancer, §FAP: Familial
adenomatous polyposis.
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study was approved by the Ethics Committee. The study
protocol was carried out in accordance with the Helsinki
Declaration as revised in 1989. All subjects were informed
about the study protocol and written consent was obtained
from each one.
2.2. Endoscopic and pathological evaluation of adenomas
The goal was to reach the cecum, achieve sufficient bowel
preparation for the colonoscopic procedure, and ensure
endoscopic removal of all detected polyps in all patients.
When the patient had insufficient bowel preparation for
the colonoscopic procedure or had at least 5 adenomas or
adenomas that were at least 2 cm in size, the colonoscopic
procedure was performed more than once.
We analyzed the number, size, location, and
morphology of adenomas at baseline colonoscopy and the
existence of villous elements and degree of dysplasia on
pathology. Dysplasia was divided into two types: low-grade
dysplasia (including moderate) and high-grade dysplasia.
Adenomas were separated into the following categories
according to the World Health Organization criteria (14).
AA was defined as an adenoma of diameter ≥10 mm or a
villous component or high-grade dysplasia. The adenoma
location was classified as the left side (splenic flexure,
descending colon, sigmoid colon, and rectum), right side
(cecum, ascending, and transverse colon), or both (for
patients with more than 1 adenoma located in both sides).
2.3. Statistical analysis
Standard procedures in SPSS, version 11.5, were used for
statistical analysis. The Shapiro–Wilk test was used to
see whether or not the distribution of discrete numeric
variables was close to normal. The Levene test was used to
assess the homogeneity of variances. Descriptive statistics
were expressed as means ± standard deviation for discrete
numeric variables, and as a number or percentage of cases
for categorical variables.
The significance of differences of average values
between groups was assessed by Student’s t test when
there were two independent groups and by one-way
ANOVA when there were more than two independent
groups. Wilcoxon’s signed rank test was used to investigate
the significance of intragroup differences in the median
number of adenomas found at baseline colonoscopy and
at 3-year follow-up colonoscopy.
Pearson’s chi-square test, Fisher’s exact test or likelihood
ratio test was used to assess categorical variables. P values
of 0.05 were considered significant.
3. Results
The rate of high-risk adenomas was 3.75% in a total of 3594
colonoscopies (n = 135). Out of the 135 high-risk patients,
47 patients (35%) who had a 3-year follow-up colonoscopy
were included in the study. Among a total of 47 patients,
72.3% were male and 27.7% were female (2.6/1; n = 34/13,
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respectively). The mean age of the patients was 55.81 ±
10.84 (mean ± standard error of the mean; range 28–77)
at the baseline colonoscopy. The patients’ descriptive
characteristics are provided in Table 1. When the patients
were divided into age groups, the frequency of adenomas
was highest in the age group of 50–59 (34%, n = 16)
(Figure 2).
At the baseline colonoscopy, a total of 136 adenomas
were removed from 47 patients. The number of adenomas
per patient was 2.7. The characteristics of adenomas
detected at the baseline colonoscopy and the 3-year followup colonoscopy are provided in Table 2.

Table 1. Patient clinical characteristics at baseline (n = 47).
Characteristics

No. of patients (%)

Age (years)
<50

13 (27.7)

50–59

16 (34.0)

60–69

13 (27.7)

≥70

5 (10.6)

Male

34 (72.3)

Female

13 (27.7)

Left site

35 (74.5)

Right site

1 (2.1)

Both

11 (23.4)

Sex

Location
‡
§

¶

No. of adenomas
1

17 (36.2)

2

11 (23.4)

≥3

19 (40.4)

Indications for colonoscopy
Constipation

21 (44.7)

Rectal bleeding

9 (19.1)

Abdominal pain

12 (25.5)

Anemia

2 (4.3)

Chronic diarrhea

3 (6.4)

: Adenomas in the splenic flexure, descending colon, sigmoid
colon, and rectum.
§
: Adenomas in the cecum, ascending, and transverse colon.
¶
: Adenomas in both left and right side of colon and rectum.
‡
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Figure 2. Patients according to age groups.
Table 2. Adenoma characteristics at baseline and endpoint colonoscopy.
Baseline adenomas
(n = 136) (%)

All recurrences
(n = 63) (%)

Advanced recurrences*
(n = 12 ) (%)

1

17 (12.5)

6 (28.6)

5 (62.5)

2

22 (16.2)

2 ( 9.5)

1 (12.5)

≥3

97 (71.3)

13 (61.9)

2 (25.0)

< 5 mm

68 (50.0)

41 (65.1)

1 ( 8.3)

5–9 mm

23 (16.9)

9 (14.3)

2 (16.7)

10–19 mm

36 (26.5)

9 (14.3)

5 (41.7)

≥ 20 mm

9 ( 6.6)

4 ( 6.3)

4 (33.3)

Tubular

106 (77.9)

56 (88.9)

5 (41.7)

Tubulovillous

22 (16.2)

5 ( 7.9)

5 (41.7)

Villous

8 ( 5.9)

2 ( 3.2)

2 (16.6)

ªHGD

3

2

2

LGD

0

1

0

Left site

84 (61.8)

13 (20.6)

2 (16.7)

Right site

1 ( 0.7)

7 (11.1)

2 (16.7)

Both

51 (37.5)

43 (68.3)

8 (66.6)

Characteristics
No. of adenomas

Size

Histological type of adenomas

b

Location
‡
§

¶

*: Advanced recurrences include adenomas ≥1 cm in size or with tubulovillous/villous histology.
: Adenomas in the splenic flexure, descending colon, sigmoid colon, and rectum.
§
: Adenomas in the cecum, ascending, and transverse colon.
¶
: Adenomas in both left and right side of colon and rectum.
ª: High-grade dysplasia.
b
: Low-grade dysplasia.
‡
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At the 3-year follow-up colonoscopy, at least one new
adenoma was found in 40.4% of the patients (n = 19) and
at least one recurrent AA was detected in 10.6% (n = 5).
Following the removal of 136 adenomas by polypectomy,
it was found that 63 new adenomas [12 of which were AAs
(19%)] developed within 3 years and tubular adenoma
was found to be the most common type of recurrent

adenomas. The most frequent location of AR was on both
sides of the colorectum simultaneously. The most common
type of new adenomas detected in the 3-year follow-up
was diminutive adenomas (<5 mm) (Figure 3).
The baseline colonoscopy findings and the
characteristics of adenomas of patients with or without AR
in the 3-year follow-up colonoscopy are shown in Table 3.

Figure 3.Size of adenomas at baseline and follow-up colonoscopy.
Table 3. Baseline characteristics of adenomas and patients according to adenoma recurrence.
Adenoma recurrence
Characteristics

Yes; n = 19 (40%)

No; n = 28 (60%)

Age (years)

55.4 ± 9.0

56.1 ± 12.1

15 (78.9)

19 (68)

*P value
0.843

Sex
Male
Female

4 (21.1)

0.404
9 (32)

0.409

No. of adenomas
1

7 (36.8)

2

5 (26.3)

≥3

7 (36.8)

10 (35.7)

0.457

6 (21.4)

0.232

12 (42.9)

0.232

11 (39.3)

0.658

17 (60.7)

0.662

Histology
High risk

§

10 (52.6)

Low risk

9 (47.4)

‡

Size of adenomas
<1 cm

16 (84.2)

≥1 cm

3 (15.8)

20 (71.4)

0.142

8 (28.9)

0.140

21 (75.0)

0.919

Location
a

Left side

b

Right side

c

Both

14 (73.7)
1 ( 5.3)
4 (21)

0 (0.0)
7 (25.0)

: Adenoma with villous component and/or high-grade dysplasia.
: Tubular adenoma ± low-grade dysplasia.
a
: Adenomas in the splenic flexure, descending colon, sigmoid colon, and rectum.
b
: Adenomas in the cecum, ascending, and transverse colon.
c
: Adenomas in both left and right side of colon and rectum.
*
P value of 0.05 was considered significant.
§

‡
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There were no significant age or sex differences between
the groups (P = 0.843 and P = 0.616, respectively). Sixtythree new adenomas were detected in a total of 19 patients
(40.4%) and 12 AAs were detected in 5 patients (10.6%)
in the third year. Comparisons were made between the
patients with and without recurrent adenomas and no
significant difference was found in size (≥1 cm) (P = 0.143),
number (≥3) (P = 0.562), histological high-risk properties
(villous component and/or dysplasia) (P = 0.658), or
location (P = 0.567) of adenomas. Regression analysis was
performed separately for each risk factor and it was found
that size, number, histological properties, and location
of adenomas were not determinants of new adenoma
development (Table 4). Then the correlation between AAs
detected at baseline colonoscopy and recurrent adenomas/
AAs was explored and it was found that baseline AAs
were also not a determinant of adenoma/AA recurrence
(OR: 2.318/2.314; 95% CI: 0.415/0.435, 2.162/2.435; P
= 0.817/0.912, respectively). In addition, size (≥1cm)
and histological high-risk properties of adenomas were
evaluated together and they did not have any predictive
value for adenoma/AA recurrence (OR: 3.346/4.402; 95%
CI: 0.498/0.326, 1.483/2.465; P = 0.687/0.423, respectively).
However, it was found that the coexistence of two features,
namely size (≥1 cm) and histological high-risk properties
(villous component and/or high-grade dysplasia), was
more common in patients with AR (42.1%) versus those
without AA (28.6%), but this difference was not significant
(P = 0.720).

When the role of baseline adenoma characteristics
(size, number, location, and histology) as potential
predictors of AA recurrence was investigated, none of the
features were shown to be useful in determining the risk of
AA recurrence (Table 5).
4. Discussion
The data of the National Polyp Study (15–17), a large
longitudinal study on the surveillance of adenoma patients,
showed that there was a reduction by 76%–90% in the
development of CRC following colonoscopic polypectomy.
Strock et al. (18) reported a very low incidence of CRC in
patients who were taken into a follow-up program due
to adenoma detection in basal colonoscopy (0.40/1000
years). In a recent study, Zauber et al. (19) suggested that
removal of colorectal adenomas by polypectomy prevents
death from CRC. Kolligs et al. (20) found an association
between male sex and AA based on findings obtained
from screening colonoscopy. In our study no association
was found between sex or age and AR. This result must
have been influenced by the small sample size of our study.
Recently, van Heijningen et al. (21) reported that the
rate of AA recurrence was 7% and the rate of AR was
32% among their patients at the follow-up colonoscopy.
In the Funen Adenoma Follow-up Study, Jørgensen et al.
(22) determined that the rate of AR was 35% in patients
who had follow-up colonoscopy 2 years after the initial
colonoscopy and 35.5% in those who had follow-up
colonoscopy 4 years after the initial colonoscopy. In the

Table 4. Association of baseline characteristics with adenoma recurrence at 3 years.

Baseline variable

Adenoma recurrence
OR

95% CI

*P value

Age (per 10-year increase)

0.994

0.942, 1.050

0.838

Sex (male vs. female)

1.776

0.457, 6.910

0.407

Number (per 1 increase)

1.881

0.807, 4.384

0.143

Size (≥1cm vs. <1 cm)

1.500

0.380, 5.928

0.737

Histology (tubular adenomas vs. high risk)

1.309

0.396, 4.323

0.658

0.933

0.246, 3.536

0.919

0.800

0.198, 3.230

0.754

Location
Left side

‡

Right side

¶

Both

§

: Adenomas in the splenic flexure, descending colon, sigmoid colon, and rectum.
: Adenomas in the cecum, ascending, and transverse colon.
§
: Adenomas in both left and right side of colon and rectum.
*: P value of 0.05 was considered significant.
‡

¶
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Table 5. Association of baseline characteristics with advanced adenoma recurrence at 3 years.
Advanced adenoma recurrence
Baseline variable

OR

95% CI

*P value

Age (per 10-year increase)

1.984

0.845, 1.150

1.000

Sex (male vs. female)

0.625

0.063, 6.180

0.517

Number (per 1 increase)

2.318

0.415, 0.384

0.445

Size (≥1 cm vs. <1 cm)

1.330

0.818, 2.162

0.667

Histology (tubular adenomas vs. high risk)

2.700

0.405, 18.002

0.990

1.419

0.143, 3.536

1.000

0.800

0.080, 8.007

0.567

Location
‡

Left side

¶

Right side

Both

§

: Adenomas in the splenic flexure, descending colon, sigmoid colon, and rectum.
: Adenomas in the cecum, ascending, and transverse colon.
§
: Adenomas in both left and right side of colon and rectum.
*: P value of 0.05 was considered significant.
‡

¶

present study, the rate of AR and AA recurrence was 40%
and 10.6% respectively. This result was in agreement with
the literature.
Studies
that
investigate
baseline
adenoma
characteristics affecting the development of colorectal
adenomas identified the following features as risk factors:
villous component, high-grade dysplasia, and size, number,
and location of adenomas (17,22–30). Noshirwani et al.
(29) studied 697 patients who underwent colonoscopic
polypectomy and found that 63 patients (9%) had AR at
3-year follow-up. They reported that the mean followup duration was 18 months. In addition, they showed
by multiple regression analyses that the number (≥3)
and size of adenomas (≥1 cm) were associated with AR.
Bonithon-Kopp et al. (31) suggested that the number of
adenomas and their proximal location at baseline were the
main predictors of recurrence. In another study, Laiyemo
et al. (26) divided the patients with adenomas at initial
colonoscopy into two groups: high-risk patients and lowrisk patients. They performed follow-up colonoscopy on
their patients 4 years after the initial colonoscopy and
suggested that AA recurrence was associated with size (≥1
cm), high-grade dysplasia, and villous histology, and was
not associated with the number of adenomas. Martinez et
al. (32) suggested that adenomas of larger sizes or those
located proximal to the colon affected AA recurrence and
the number of adenomas had significant association with
AR, but villous histology did not play a significant role in
the recurrence. In another study from Korea, the authors
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reported that number (≥3) and size (>1 cm) of adenomas
increased the risk of AA recurrence; however, histological
properties did not play a role in the increased risk (33).
Contrary to the results of these studies, in our study it was
found that the number (≥3), size (≥1 cm), location, and
histological properties of adenomas (villous component
and/or high-grade dysplasia) that were identified as
initial adenoma characteristics did not play a role in
the increased risk for recurrence. This might have been
caused by the limited number of patients, short followup duration, inclusion of exclusively high-risk patients in
the study, and the absence of comparisons with low-risk
patients. Moreover, the quality of preliminary preparation
for initial colonoscopy was not assessed in this study. Since
colorectal carcinogenesis is a slow process, long follow-up
duration increases the possibility of accurately identifying
the determinants of AR. There is no consensus among
the studies on the determining roles of initial adenoma
features in recurrence. Recently, Rosa et al. (34) have
published the results of their study of 156 patients who
were followed up by colonoscopy for 48 to 232 months.
In agreement with the results of our study, the authors of
that study found no significant correlations between the
number, the presence of villous component, or the size
of adenomas at index colonoscopy and the presence of
adenomas at subsequent colonoscopies. In another study,
colonoscopic data of 44 patients who were screened 24–26
months after initial colonoscopy were published and it was
reported that histological properties, size, and location of
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adenomas were not associated with AR (35). Recently, it has
been suggested that studies investigating AR have various
limitations. Van Stolk et al. (25) reported that number
(≥3) and type of baseline adenomas predicted recurrent
adenomas and they pointed out that this was caused by
polyps that were missed at the initial colonoscopy. The
same opinion was also suggested by Lorenzo-Zúñiga et
al. (36). In many studies, the number of adenomas was
reported to be a significant risk factor in AR. The main
reason behind these results may be polyps that are missed
at the initial colonoscopy. This may also affect the results
that are related to the other adenoma features, which is
also true for our study.
There are various limitations to be addressed in the
present study. Firstly, the sample size was relatively small,
which may have affected the statistical data. Secondly, the
quality of preliminary preparation for initial colonoscopy
was not assessed in this study. Thirdly, follow-up duration

was relatively short. Colorectal carcinogenesis is a long
process and development of new adenomas may take a
while.
In conclusion, the most common type of recurrent
adenoma in the present study was tubular and diminutive
adenoma (<5 mm), and AR most frequently occurred in
both segments of the colon simultaneously. There was no
association between AR and age or sex in patients with
high-risk adenoma. In addition, initial adenoma features
(size: ≥1cm, number: ≥3, location and villous component,
and/or high-grade dysplasia) were not associated with and
did not play a determining role in adenoma/AA recurrence
at the 3-year follow-up colonoscopy in patients with highrisk adenoma. AA detected at the initial colonoscopy was
also not a determinant of AR. AA should be monitored
in shorter intervals independently for the component that
makes an adenoma an AA.
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